180 related articles for article (PubMed ID: 24362689)
1. The adaptive immune response to respiratory syncytial virus.
Varga SM; Braciale TJ
Curr Top Microbiol Immunol; 2013; 372():155-71. PubMed ID: 24362689
[TBL] [Abstract][Full Text] [Related]
2. Consequences of immature and senescent immune responses for infection with respiratory syncytial virus.
Malloy AM; Falsey AR; Ruckwardt TJ
Curr Top Microbiol Immunol; 2013; 372():211-31. PubMed ID: 24362692
[TBL] [Abstract][Full Text] [Related]
3. Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8
Lee JY; Chang J
J Microbiol; 2017 Nov; 55(11):900-908. PubMed ID: 29076066
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the host immune response by respiratory syncytial virus proteins.
Schmidt ME; Varga SM
J Microbiol; 2017 Mar; 55(3):161-171. PubMed ID: 28243940
[TBL] [Abstract][Full Text] [Related]
5. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
[TBL] [Abstract][Full Text] [Related]
6. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.
Garg R; Shrivastava P; van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388
[TBL] [Abstract][Full Text] [Related]
7. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus vaccine development.
Hurwitz JL
Expert Rev Vaccines; 2011 Oct; 10(10):1415-33. PubMed ID: 21988307
[TBL] [Abstract][Full Text] [Related]
9. The role of IFN in respiratory syncytial virus pathogenesis.
Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
[TBL] [Abstract][Full Text] [Related]
10. Human Respiratory Syncytial Virus: An Introduction.
Jorquera PA; Anderson L; Tripp RA
Methods Mol Biol; 2016; 1442():1-12. PubMed ID: 27464683
[TBL] [Abstract][Full Text] [Related]
11. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.
Collins PL; Melero JA
Virus Res; 2011 Dec; 162(1-2):80-99. PubMed ID: 21963675
[TBL] [Abstract][Full Text] [Related]
12. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
[TBL] [Abstract][Full Text] [Related]
13. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM
Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218
[TBL] [Abstract][Full Text] [Related]
14. Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection.
Lee YT; Kim KH; Hwang HS; Lee Y; Kwon YM; Ko EJ; Jung YJ; Lee YN; Kim MC; Kang SM
Virology; 2015 Nov; 485():36-46. PubMed ID: 26196232
[TBL] [Abstract][Full Text] [Related]
15. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
Kotomina T; Isakova-Sivak I; Matyushenko V; Kim KH; Lee Y; Jung YJ; Kang SM; Rudenko L
Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351
[TBL] [Abstract][Full Text] [Related]
16. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
Sarkar I; Garg R; van Drunen Littel-van den Hurk S
Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951
[TBL] [Abstract][Full Text] [Related]
17. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
[TBL] [Abstract][Full Text] [Related]
18. Host genetic determinants of vaccine-induced eosinophilia during respiratory syncytial virus infection.
Hussell T; Georgiou A; Sparer TE; Matthews S; Pala P; Openshaw PJ
J Immunol; 1998 Dec; 161(11):6215-22. PubMed ID: 9834108
[TBL] [Abstract][Full Text] [Related]
19. Host Components Contributing to Respiratory Syncytial Virus Pathogenesis.
Carvajal JJ; Avellaneda AM; Salazar-Ardiles C; Maya JE; Kalergis AM; Lay MK
Front Immunol; 2019; 10():2152. PubMed ID: 31572372
[TBL] [Abstract][Full Text] [Related]
20. Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.
Schijf MA; Lukens MV; Kruijsen D; van Uden NO; Garssen J; Coenjaerts FE; Van't Land B; van Bleek GM
PLoS One; 2013; 8(11):e81695. PubMed ID: 24303065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
